Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orthokine (autologous conditioned serum) in horizontal bone augmentation or socket preservation
IRCT20180905040955N2Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2021
- Countries
- 1
01
Overview
Phase 3, open-label trial of autologous conditioned serum in Alveolar ridge defect and tooth extraction socket defect (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Alkaline phosphatase activity, Tissue mineralization rate and 4 more. Started Aug 2021; status: completed.
02
Drugs
autologous conditioned serum
03
Conditions
Alveolar ridge defecttooth extraction socket defect
Beyond the preview
Go deeper on IRCT20180905040955N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180905040955N2.